Anti-infective catheters: A difficult search for effective slow delivery systems;Antimikrobielle kathetermaterialien: Schwierige suche nach wirksamen wirkstoffliberations-systemen

Materialwissenschaft und Werkstofftechnik

Volumn 30, Issue 12, 1999, Pages 869-875

  Schierholz, J M ^a   Beuth, J ^a   Rump, A F E ^a   Konig D P ^a   Pulverer, G ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0033474474     PISSN: 09335137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1521-4052(199912)30:12<869::aid-mawe869>3.3.co;2-7     Document Type: Article

References (99)

1. 1. Martone, W.J., Jarvis, W.R., Culver, D.H., Haley, R.W., Incidence and nature of endemic and epidemic nosocomial infections. In: Bennett JV, Brachmann PS eds. Hospital Infections. 1992: 577-592.
2. 2. Jarvis, W.R., Edwards, J.R., Culver, D.H. et al: Nosocomial infection rates in adult and pediatric intensive care units in the United States. Am J Med 1991; 91: 1855-1915.
3. 3. Maki, D.G., Nosocomial bacteremia. A epidemiologic overview. Am. J. Med. 1981; 70: 719-732.
4. 4. Maki, D.G., Pathogenesis, prevention, and management of infections due to intravascular devices used for infusion therapy. In: Infections associated with indwelling medical devices, ed. by Bisno, A.L., F.A. Waldvogel. American Society of Microbiology, Washington 1989: 161-177.
5. 5. Moro, M.L., Vigano, E.F., Cozzi Lepri, A., Risk factors for central venous catheter-related infections in surgical and intensive care units. The central venous catheter-related infections study group. Inf. Contr. Hosp. Ep. 1994; 15: 253-264.
6. 6. Nyström, B., Bacteraemia in surgical patients with intravenous devices: a European multicenter incidence study. Hosp. Inf.; 1983; 4: 338-349.
7. 7. Pittet, D., Wenzel, R.P., Nosocomial bloodstream infections in the critically III. JAMA 1994; 272/23: 1819-1820.
8. 8. Mermel, L.A., McCormick, R.D., Springman, S.R., Maki, D.G., The pathogenesis and epidemiology of catheter-related infection with pulmonary artery Swan-Ganz catheters: a prospective study utilizing molecular subtyping. Am. J. Med. 1991; Suppl. 3b: 197S-205S.
9. 9. Salzman, M.B., Isenberg, H.D., Shapiro, J.F., Lipsitz, P.J., Rubin, L.G., A prospective study of the catheter hub as the portal of entry for microorganisms causing catheter-related sepsis in neonates. J I D 1993; 167: 487-490.
10. 10. Keohane, P.P., Jones, B.J., Attrill, H., Cribb, A., Northover, J., Frost, P., Silk D.B., Effect of catheter tunnelling and a nutrition nure on catheter sepsis during parenteral nutrition. A controlled trial. Lancet 1983; II: 1388-1390.
11. 11. Segura, M., Alía, C., Oms, L., Sancho, J., Torres-Rodríguez, J.M., Sitges-Serra, A., In vitro bacteriological study of a new hub model for intravascular catheters and infusion equipment. J Clin Microbiol 1989; 27: 2656-2659.
12. 12. Segura, M., Alvarez-Lerma, F., Tellado, J.M., Jiménez-Ferreres, J., Oms, L., Rello, J., Baró, T, Sanchez, R., Morera, A., Mariscal, D., Marrugat, J., Sitges-Serra, A., A clinical trial on the prevention of catheter-related sepsis using a new hub model. Ann. Surg. 1996; 223/4: 363-369.
13. 13. Sherertz, R.J., Heard, S.O., Raad, II., Diagnosis of triple-lumen catheter infection: comparison of roll plate, sonication, and flushing methodologies. J. Clin. Microbiol. 1997; 35: 641-646.
14. 14. Sitges-Serra, A., Linares, J., Garau, J., Catheter sepsis: the clue is the hub. Surgery 1985; 97: 355-357.
15. 15. Sitges-Serra, A., Pi-Suner, T., Garces, J.M., Segura, M., Pathogenesis and prevention of catheter-related septicemia. Am. J. Infection Control 1995; 23: 310-316.
16. 16. Chuang, J.H., Chuang, S.F., Implication of a distant septic focus in parenteral nutrition catheter colonization. J. Parenteral Enteral Nutr. 1991; 15: 173-175.
17. 17. Arrow, P.M., Quimosing, E.M., Beach, M., Consequences of intravascular sepsis. Clin. Infect. Dis. 1993; 16: 778-784.
18. 18. Kurkchubasche, A.G., Smith, S.D., Rowe, M.I., Catheter sepsis in short-bowel syndrome. Arch. Surg. 1992; 127: 21-25.
19. 19. Christensen, G.D., The sticky problem of staphylococcus epidermidis sepsis. Hosp. Practice 1993; 30: 27-36.
20. 20. Schierholz, J.M., Beuth, J., Pulverer, G., Adherent Bacteria and Activity of Antibiotics. JAC 43: 158-160 (1999).
21. 21. Costerton, J.W., Cheng, K.J., Geesey, G.G., Ladd, T.I., Nickel, J.C., Dasgupta, M., Marrie, T.J., Bacterial biofilms in nature and disease. Ann. Rev. Microbiol. 1987; 41: 435-464.
22. 22. Guggenbichler, J.P., Berchtold, D., Allerberger, F., Bonatti, H., Hager, J., Pfaller, W., Dierich, M.P., In vitro and in vivo effect of antibiotics on catheters colonized by staphylococci. Eu. J. Clin. Microbiol. Infect. Dis. 1992: 408-415.
23. 23. Sheth, N.K., Franson, T.R., Sohnle, P.G., Influence of bacterial adherence to intravascular catheters on in-vitro antibiotic susceptibility. Lancet 1985; 2: 1266-1268.
24. 24. Widmer, A.F., In Wenzel RP, ed. Prevention and control of nosocomial infections. Baltimore, Maryland, Williams & Wilkins, 1993, 556-579.
25. 25. Kohnen, W., Novel antiinfective biomaterials by polymer modification. In: Biotechnology and bioactive Polymers. Eds. Charles G., Plenum Press 1996; 317-326
26. 26. Dumitriu, S., Popa, M.I., Haulacia, I., Cringu, A., Stratone, A., Bioactive polymers 61. synthesis and characterization of some retard antibiotics. Colloid Polym. Sci. 1989; 267: 595-599.
27. 27. Simionescu, C.I., Dumitriu, S., Popa, M.I., Denisova, L., Antibiotics immobilized on polysaccharides. Makromol. Chem. Suppl. 1985; 9: 179-187.
28. 28. Solovskij, M.V., Ulbrich, K., Kopecek, J., Synthesis of N-(2-hydroxypropyl) methacrylamide copolymers with antimicrobial activity. Biomat. 1983; 4: 44.
29. 29. Williams, R.L., Doherty, P.J., Vince, D.G. et al.: The biocompatibility of silver. Crit. Rev. Biocomp. 1989; 5: 221-243.
30. 30. Macmillan Publishing Company, New York, Collier Macmillan Canada, Inc., Toronto, Collier Macmillan Publishers, London: Goodman and Gilman's - The pharmacological basis of therapeutics. Seventh Edition, 1985; 963-967.
31. 31. Becker, R.O., Spadaro, J.A., Treatment of orthopedic infections with electrically generated silver ions. J. Bone Jt. Surg. 1978; 60(A): 871.
32. 32. Benvenisty, A.I., Tannenbaum, G., Alhorn, T.N., Fox, C.L., Modak, S., Sampath, L., Reemtsma, K, Nowygrod, R., Control of prosthetic bacterial infection: evaluation of an easily incorporated, tightly bound, silver antibiotic PFTE graft. J. Surg. Res. 1988; 44: 1.
33. 33. Colmano, G., Edwards, S.S., Barranco, S.D., Activation of antibacterial silver coatings on surgical implants by direct current: preliminary studies in rabbits. Am. J. Vet. Res. 1980; 41: 964.
34. 34. Chu, C.C., Tsai, W.C., Yao, J.Y., Chiu, S.S., Newly made antibacterial braided nylon sutures. I. In vitro qualitative and in vivo preliminary biocompatibility study. J. Biomed. Mater. Res. 1987; 21: 1281.
35. 35. Deitch, E.A., Marino, A.A., Gillespie, T.E., Albright, J.A., Silver-nylon: a new antimicrobial agent. Antimicrob. Agents Chemother. 1983; 23: 356.
36. 36. Falone, A.E., Spadaro, J.A., Inhibitory effects of electrically activated silver material on cutaneous wound bacteria. Plast. Reconstruc. Surg. 1983; 77: 455.
37. 37. Furr, J.R., Russell, A.D., Turner, T.D., Andrews, A., Antibacterial activity of actisorb plus, Actisorb and silver nitrate. J. Hosp. Inf. 1994; 27: 201-208.
38. 38. Schaeffer, A.J., Story, K.O., Johnson, S.M., Effect of silver oxide/trichloroisocyanuric acid antimicrobial urinary drainage system on catheter-associated bacteriuria. J. Urol. 1988; 139: 69.
39. 39. Tsai, W.C., Chu. C.C., Chin, S.S., Yao, J.Y., In vitro quantitative study of newly made antibacterial braided nylon sutures. Surg. Gynecol. Obstet. 1987; 165: 207.
40. 40. Spadaro, J.A., Chase, S.E., Webster, D.A., Bacterial inhibition by electrial activation of percutaneous silver implants. J. Biomed. Mater. Res. 1986; 20: 565.
41. 41. Bambauer, R., Mestres, P., Schiel, R., Sloshansi, P., New surface-treatment technologies for catheters used for extracorporeal detoxification methods. Dial. Transpl. 1995; 24 (5): 228-237.
42. 42. Bambauer, R., Schiel, R., Mestres, P., Sioshansi, P., Scanning electron microscopic investigations of surface treated largebore catheters used for extracorporeal detoxification methods. Int. J. Art. Org. 1995; 18 (5): 326-331.
43. 43. Sioshansi, P., New processes for surface treatment of catheters. Art. Org. 1994; 18 (4): 266-271
44. 44. Liedberg, H., Lundeberg, T., Silver alloy coated catheters reduce catheter-associated bacteriaemia. Brit. J. Urol. 1990; 65: 379-381.
45. 45. McLean, R.J.C., Hussain, A.A., Sayer, M., Vincent, P.J., Hughes, D.J., Smith, T.J.N., Antibacterial activity of multilayer silver-copper surface film on catheter material. Can. J. Microbiol. 1993; 39: 895-899.
46. 46. Maki, D.G., Cobb, L., Garman, J.K., Shapiro, J.M., Ringer, M., Helgerson, R.B., An attachable silver-impregnated cuff for prevention of infection with central venous catheters: a prospective randomized multicenter trial. JAMA 1988; 85: 307-316.
47. 47. Babycos, C.R., Barrocas, A., Webb, W.R., A prospective randomized trial comparing the silver-impregnated collagen cuff with the bedside turned subclavian catheter: Par. Nutr. 1993; 17/1: 61-63.
48. 48. Flowers, R., Schwenzer, K.J., Kopel, R.F., Finch, M.J., Tucker, S.I., Farr, B.M., Efficacy of an attachable subcutaneous cuff for the prevention of intravascular catheter-related infection. A randomized, controlled trial. J. Amer. Med. Ass. 1989; 261: 878-883.
49. 49. Girvent, M., Failure of silver impregnated subcutaneous cuffs to prevent intravascular catheter infection. An. Surg. 1995; 221: 115-116.
50. 50. Dahlberg, P.J., Agger, W.A., Singer, J.R., Yutuc, W.R., Newcomer, K.L., Schaper, A., Rooney, B.L., Subclavian hemodialysis catheter infections: a prospective, randomized trial of an attachable silver-impregnated cuff for prevention of catheter-related infections. Infect. Control. Hosp. Epidemiol. 1995; 16: 506-511.
51. 51. Riley D.K., Classen D.C., Stevens L.E., Burke J.P., A Large Randomized Clinical Trial of a Silver-Impregnated Urinary Catheter: Lack of Efficacy and Staphylococcal Superinfection. JAMA 1995; 98: 349-358.
52. 52. Schierholz, J.M., Beuth, J., Pulverer, G., Silver coating of medical devices for catheter-associated infections? Am. J. Med. 1999; 107(1): 101-102.
53. 53. Schierholz, J.M., Lucas, L., Pulverer, G., Silver coating of medical devices - A review J. Hosp. Inf. 1998; 40: 257-262.
54. 54. Rungby, J., Hultman, P., Ellermann-Eriksen, S., Silver affects viability and structure of cultured mouse peritoneal macrophages and perioxidative capacity of whole mouse liver. Arch Toxicol 1987; 59: 408-412.
55. 55. Rungby, J., An experimental study on silver in the nervous system and on aspects of its general cellular toxicity. Dan. Med. Bull. 37 (5): 442-449.
56. 56. Rungby, J., Experimental Argyrosis: Ultrastructural Localization of silver in rat eye. Exp. Mol. Path. 1986; 45: 22-30.
57. 57. Rungby, J., Ellermann-Eriksen, S., Danscher, G., Effects of selenium on toxicity and ultrastructural localization of silver in cultured macrophages. Arch Toxicol 1987; 61: 40-45.
58. 58. Sudmann, E., Vik, H., Rait, M., Todnem, K., Andersen, K.J., Julsham, K., Muscle paralysis in a patient with total hip prosthesis and silver-impregnated antibacterial bone cement. Act. Orth. Scand. 1985; 56: 534.
59. 59. Jansen, B., Jansen, S., Peters, G., Pulverer, G., In-vitro efficacy of a central venous catheter ("Hydrocath") loaded with teicoplanin to prevent bacterial colonization. Hosp. Inf. 1992; 22: 93-107.
60. 60. Jansen, B., Kristinsson, K.G., Jansen, S., Peters, G., Pulverer, G., In-vitro efficacy of a central venous catheter complexed with iodine to prevent bacterial colonization. Antimicrob. Chem. 1992; 30: 135-139.
61. 61. Tebbs, S.E., Elliott, T.S.J., A novel antimicrobial central venous catheter impregnated with benzalkonium chloride. J. Antimicr. Chem. 1993; 31: 261-271.
62. 62. Tebbs, S.E., Ellioit, T.S.J., Modification of central venous catheter polymers to prevent in vitro microbial colonisation. Eur. J. Clin. Microbiol. Infect. Dis. 1994; 13: 111-117.
63. 63. Kamal, G.D., Pfaller, M.A., Rempe, L.E, Jebson, R.J.R., Reduced intravascular catheter infection by antibiotic bonding. A prospective, randomized, controlled trial. JAMA 1991; 265: 2364-2368.
64. 64. Nosher, J.L., Ericksen, A.S., Trooskin, S.Z., Needell, G.S., Harvey, R.A., Greco R.S., Antibiotic bonded nephrostomy catheters for percutaneous nephrostomies. Cardiovasc. Int. Rad., 1990; 13(2): 102-6.
65. 65. Trooskin, S.Z., Harvey, R.A., Lennard, T.W., Greco, R.S., Failure of demonstrated clinical efficacy of antibiotic-bonded continuous ambulatory peritoneal dialysis (CAPD) catheters. Periton. dial. int., 1990; 10(1): 57-9.
66. 66. Mermel, L.A., Stolz, S.M., Maki, D.G., Surface antimicrobial activity of heparin-bonded and antiseptic-impregnated vascular catheters. Inf. Dis. 1993; 167: 920-92.
67. 67. Sampath, L.A., Chowdhury, N., Caraos, L., Modak, S.M., Infection resistance of surface modified catheters with either short-lived or prolonged activity. J. Hosp. Infect. 1995; 30: 201-210.
68. 68. Bach, A., Böttiger, B., Böhrer, H., Motsch, J., Martin, E., Retention of the antibiotic teicoplanin on a hydromer-coated central venous catheter to prevent bacterial colonization in postoperative surgical patients. Int. Care Med. 1996; 22: 1066-1069.
69. 69. Bergeron, M.G., Robert, J., Beauchamp, D., Pharmacodynamics of antibiotics in fibrin clots. Antimicr. Chem. 1993; 31 Suppl. D: 113.
70. 70. Gutschik, E., The enterococcus endocarditis model in experimental animals and its relevance to human infection. Antimicr. Chem. 1993; 31 Suppl. D: 87.
71. 71. Barza, M., Pharmacokinetics of antibiotics in shallow and deep compartments. Antimicr. Chem. 31 Suppl. D 1993; 17.
72. 72. Olanoff, L.S., Anderson, J.M., Jones, R.D., Sustained release of gentamicin from prosthetic heart valves. Trans. Am. Soc. Artif. Intern. Organs 1979; 25: 334-338.
73. 73. Kingston, D., Birnie, E.D.C., Martin, J., Pearce, P.C., Manek, S., Quinn, C.M., Experimental pathology of intravenous polyurethane cannulae containing disinfectant. J Hosp Infect 1992; 20: 257-270.
74. 74. Kingston, D., Hill, I.D., Elution of disinfectant from polyurethane cannula tubing. J Hosp Inf. 1990; 16: 271-280.
75. 75. Seal, D.V., Barren, S.P., The development of irgasan-impregnated intravenous cannulae. In: Wadström J, Eliasson I, Holder I, Ljungh A, eds. Pathogenesis of wound and biomaterial-associated infections. London, Berlin, Heidelberg, New York, Springer, 1990, 501-506.
76. 76. Solomon, D.D., Sherertz, R.J., Antibiotic releasing polymers. J. Contr. Rel. 1987: 343-352.
77. 77. Schierholz, J.M., Rump, A.F.E., Pulverer, G., Ciprofloxacin containing polyurethanes as potential drug delivery systems to prevent foreign-body infections. Drug Res. 1997; 47 (I), 1: 70-74.
78. 78. Sherertz, R.J., Carruth, W.A., Hampton, A.A., Byron, M.P., Solomon, D.D., Efficacy of antibiotic-coated catheters in preventing subcutaneous staphylococcus aureus infection in rabbits. J. Inf. Dis. 1993; 167: 98-106.
79. 79. Sherertz, R.J., Forman, D.M., Solomon, D.D., Efficacy of dicloxacillin-coated polyurethane catheters in preventing subcutaneous staphylococcus aureus infection in mice. Antimicr. Ag. Chem. 1989: 1174-1178.
80. 80. Schierholz, J.M., Jansen, B., Steinhauser, H., Peters, G., Schuhmacher-Perdreau, F., Pulverer, G., Drug release from antibiotic-containing polyurethanes. New Polymeric Mater 1990; 3: 61-72.
81. 81. Schierholz, J.M., Steinhauser, H., Rump, A.F.E., Berkels, R., Pulverer, G., Controlled release of antibiotics from biomedical polyurethanes: morphological and structural features. Biomat. 18: 1997.
82. 82. Hampl, J., Schierholz, J., Jansen, B., Aschoff, A., In vitro and in vivo efficacy of rifampin loaded silicone catheter in prevention of CSF-shunt infections. Acta Neurochirurg. 1995; 133: 147-152.
83. 83. Schierholz, J.M., Jansen, B., Jaenicke, L., Pulverer, G., In vitro efficacy of an antibiotic releasing silicone ventricle catheter to prevent shunt infection. Biomat. 1994; 15: 996-1000.
84. 84. Schierholz, J.M., Pulverer, G., Development of a new CSF-shunt with sustained release of an antimicrobial broad-spectrum combination. Zbl. Bakt. 1997; 286(1): 107-123.
85. 85. Schierholz, J.M, Pulverer, G., Investigation of a rifampin, fusidic-acid and mupirocin releasing silicone catheter. Biomat. 19, 2065-2074 (1998).
86. 86. Raad, I., Darouiche, R., Hachem, K., Sacilowski, M., Bodey, G.P., Antibiotics and prevention of microbial colonization of catheters. Antimicr. Ag. Chem. 1995; 39: 2397-2400.
87. 87. Raad, I., Darouiche, R., Central venous catheters (CVC) coated with minocydine and rifampicin (m/r) for the prevention of catheter-related bacteremia (CRB). ASM 1995: 258.
88. 88. Bach, A., Böhrer, H., Motsch, J., Martin, E., Geiss, H.K., Sonntag, H.G., Prevention of bacterial colonization of intravenous catheters by antiseptic impregnation of polyurethane polymers. Antimicrob. Ag. Chem. 1994; 33: 969-978.
89. 89. Maki, D.G., Stolz, S.M., Wheeler, S., Mermel, L.A., Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter. A randomized, controlled trial. Ann Int Med 127 (4), 257-66 (1997).
90. 90. Civetta, J.M., Hudson-Civetta, J., Ball, S., Decreasing catheter-related infection and hospital costs by continuous quality improvement. Crit Care Med 1996; 24 (10).
91. 91. Bach, A., Schmidt, H., Bottiger, B., Schreiber, B., Bohrer, H., Motsch J., Martin, E., Sonntag, H.G., Retention of antibacterial activity and bacterial colonization of antiseptic-bonded central venous catheters. J Antimicrob Chemother 1996, 37(2), 315-22 .
92. 92. Heard, S.O., Wagle, M., Vijayakumar, E., Doern, G., The influence of triple-lumen central venous catheters coated with chlorhexidine/silver sulfadiazine on the incidence of catheter-related bacteriemia. Arch. Intern.Med. 1998, 158: 81-87.
93. 93. Ciresi, D.L., Albrecht, R.M., Volkers, P.A., Scholten, D.J., Failure of antiseptic bonding to prevent central venous catheter related infection and sepsis. Am. Surg. 1996; 62: 641-645.
94. 94. Pemberton, L.B., Ross, V., Cuddy, P., Kremer, H., Fessler, T., McGurh, E., No difference in catheter sepsis between standard and antiseptic central venous catheters. Arch Surg 1996; 131: 986.
95. 95. Ellis, M.E., Rhydderch, D., Zwaan, F., Guy, M.L., Baillie, F., High incidence of line-related infection and mechanical failure of an antiseptic impregnated central venous catheter in highly immunocompromised patients. Scand J Infect Dis 1996; 28, 91-93.
96. 96. Logghe, C., Van Ossel, Ch., D'Hoore, W., Ezzedine, H., Wauters, G., Haxhe, J. J., Evaluation of chlorhexidine and silver-sulfadiazine impregnated cenetral venous catheters for the prevention of bloodstream infection in leukaemic patients: a randomized controlled trial. J Hosp Inf 1997; 37, 145-156.
97. 97. Veenstra, D.L., Saint, S., Somnath, S., Lumley, T., Sullivan, S.D., Efficacy of Antiseptic impregnated central venous catheters in Preventing catheter-related bloodstream infections. JAMA (1999) 281(3), 261-267.
98. 98. Schierholz, J.M., Rump, A.F.E., Pulverer, G., Beuth J., Antiinfective catheters: Novel strategies to prevent nosocomial infections in oncology, Anticancer Res. 18, 1998, 3629-3638.
99. 99. Schierholz, J.M., Wenchel, H.-M., König, D.P., Beuth, J., Pulverer, G., The Importance of Antimicrobial Slow Release Systems for the Prevention of Catheter-Associated Infections. Hyg. Med. 1998, (12), 548-556.